Polyphor plant IPO an SIX im Q2 2018 – Kapitalbeschaffung von bis zu 150 Mio CHF

Allschwil (awp) – Schon bald geht mit dem Allschwiler Biopharma-Unternehmen Polyphor die nächste Firma an die Schweizer Börse.
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
668